Cost comparison of single daily i.v. doses of ceftriaxone versus continuous infusion of cefotaxime

American Journal of Health-System Pharmacy

Volumn 54, Issue 14, 1997, Pages 1614-1618

  Hitt, Catherine M ^a   Nightingale, Charles H ^b   Quintiliani, Richard ^b   Nicolau, David P ^c  

^a MAYO CLINIC   (United States)

^b Anti Infective Res P   (United States)

^c HARTFORD HOSPITAL   (United States)

Author keywords

Cefotaxime sodium; Ceftriaxone sodium; Cephalosporins; Costs; Dosage schedules; Drug administration; Drug administration systems; Drug comparisons; Economics; Injections; Nurses; Pharmacists, hospitals; Time studies; Workload

Indexed keywords

CEFOTAXIME; CEFTRIAXONE;

ARTICLE; CONTINUOUS INFUSION; COST BENEFIT ANALYSIS; DRUG COST; HEALTH CARE COST; INTRAVENOUS DRUG ADMINISTRATION; PHARMACIST; PHARMACY; PRIORITY JOURNAL;

EID: 0030805729     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/54.14.1614     Document Type: Article

References (13)

1. Craig WA. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn Microbiol Infect Dis. 1995; 22:89-96.
2. Craig WA, Ebert SC. Continuous infusion of beta-lactam antibiotics. Antimicrob Agents Chemother. 1992; 36:2577-85.
3. Visser LG, Arnouts P, Van Furth R et al. Clinical pharmacokinetics of continuous intravenous administration of penicillins. Clin Infect Dis. 1993; 17:491-5.
4. Mouton JW, den Hollander JG. Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model. Antimicrob Agents Chemother. 1994; 38:931-6.
5. Roosendaal R, Bakker-Wouldenberg IAJM, van den Berg JC et al. Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumoniae in rats. J Infect Dis. 1985; 152:373-8.
6. Mordenti JJ, Quintiliani R, Nightingale CH. Combination antibiotic therapy: comparison of constant infusion and intermittent bolus dosing in an experimental animal model. J Antimicrob Chemother. 1985; 15(suppl A):313-21.
7. Peterson LR, Gerding DN, Fasching CE. Effects of method of administration of extravascular penetration: crossover study of cefazolin given by intermittent injection or constant infusion. J Antimicrob Chemother. 1981; 7:71-9.
8. Mouton JW, Horrevorts AM, Mulder PG et al. Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers. Antimicrob Agents Chemother. 1990; 34:2307-11.
9. Nicolau DP, Nightingale CH, Banevicius MA et al. Serum bactericidal activity of ceftazidime: continuous infusion versus intermittent injections. Antimicrob Agents Chemother. 1996; 40:61-4.
10. Neu HC. Cephalosporins - cefotaxime 10 years later, a major drug with continued use. Infection. 1991; 19(suppl 6):S309-15.
11. Claforan package insert. Somerville, NJ: Hoechst-Roussel Pharmaceuticals, Inc.; 1992.
12. Mandell LA, Bergeron MG, Ronald AR et al. Once daily therapy with ceftriaxone compared with daily multiple dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study. J Infect Dis. 1989; 160:433-41.
13. Smith CR, Petty BG, Hendrix CW et al. Ceftriaxone compared with cefotaxime for serious bacterial infections. J Infect Dis. 1989; 160:442-7.